98 related articles for article (PubMed ID: 38090328)
1. Stepwise Incremental Dose Schedule of Sirolimus Is Successfully Tolerated by a Patient With Lymphangioleiomyomatosis Who Was Initially Allergic to mTOR Inhibitors.
Seyama K; Komiyama E; Tsuchihashi H; Okura MK; Sekimoto Y; Mitsuishi Y
Cureus; 2024 Apr; 16(4):e58805. PubMed ID: 38784348
[TBL] [Abstract][Full Text] [Related]
2. Possible Novel Therapeutic Targets in Lymphangioleiomyomatosis Treatment.
Song X; Cai H; Yang C; Xue X; Wang J; Mo Y; Zhu M; Zhu G; Ye L; Jin M
Front Med (Lausanne); 2020; 7():554134. PubMed ID: 33072782
[TBL] [Abstract][Full Text] [Related]
3. Lymphangioleiomyomatosis and mTOR inhibitors in real world-a narrative review.
Park S; Lee EJ
J Thorac Dis; 2023 Nov; 15(11):6333-6344. PubMed ID: 38090328
[TBL] [Abstract][Full Text] [Related]
4. A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant.
Warrior K; Leard LE; Nair AR; Gries CJ; Fisher AJ; Johnson SR; McCormack FX; Dilling DF
Respir Med; 2022; 195():106779. PubMed ID: 35276437
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis.
Gao N; Zhang T; Ji J; Xu KF; Tian X
Orphanet J Rare Dis; 2018 Aug; 13(1):134. PubMed ID: 30107845
[TBL] [Abstract][Full Text] [Related]
6. Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation?
El-Chemaly S; Goldberg HJ; Glanville AR
Expert Rev Respir Med; 2014 Dec; 8(6):657-60. PubMed ID: 25199529
[TBL] [Abstract][Full Text] [Related]
7. mTOR treatment in lymphangioleiomyomatosis: the role of everolimus.
Yates DH
Expert Rev Respir Med; 2016; 10(3):249-60. PubMed ID: 26847859
[TBL] [Abstract][Full Text] [Related]
8. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations.
Freitas CS; Baldi BG; Araújo MS; Heiden GI; Kairalla RA; Carvalho CR
J Bras Pneumol; 2015; 41(3):275-80. PubMed ID: 26176526
[TBL] [Abstract][Full Text] [Related]
9. Determinants of Progression and Mortality in Lymphangioleiomyomatosis.
Xu W; Yang C; Cheng C; Wang Y; Hu D; Huang J; He Y; Wang J; Chen K; Yang L; Zhou W; Zhang T; Liu S; Dai J; Meng S; Li X; Yang Y; Wang ST; Feng R; Zhang W; Zhang H; Wang L; Tian X; Xu KF
Chest; 2023 Jul; 164(1):137-148. PubMed ID: 36801466
[TBL] [Abstract][Full Text] [Related]
10. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.
McCarthy C; Gupta N; Johnson SR; Yu JJ; McCormack FX
Lancet Respir Med; 2021 Nov; 9(11):1313-1327. PubMed ID: 34461049
[TBL] [Abstract][Full Text] [Related]
11. Chylous Ascites as a Presentation of Lymphangioleiomyomatosis.
McLain JH; Khadarian K; Shojaie L; Lubman R; Chang CF; Lindgren B; Shao L
ACG Case Rep J; 2021 Mar; 8(3):e00517. PubMed ID: 33681402
[TBL] [Abstract][Full Text] [Related]
12. Lymphangioleiomyomatosis.
Xu KF; Xu W; Liu S; Yu J; Tian X; Yang Y; Wang ST; Zhang W; Feng R; Zhang T
Semin Respir Crit Care Med; 2020 Apr; 41(2):256-268. PubMed ID: 32279296
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic usefulness of transbronchial lung cryobiopsy in two patients mildly affected with pulmonary lymphangioleiomyomatosis.
Yoshida M; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T
Respir Investig; 2020 Jul; 58(4):295-299. PubMed ID: 32265154
[TBL] [Abstract][Full Text] [Related]
14. Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.
Kim C; Do KH; Cha J; Song JW; Lee SM; Lee KY
Eur Radiol; 2020 Feb; 30(2):735-743. PubMed ID: 31471750
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
